Indaba Capital Management’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Indaba Capital Management’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,081,421	Closed	-$3.67M	–	58
2021 Q3	$3.67M	Buy	+1,081,421	New	+$3.85M	0.42%	35

Other funds holding DNA.WS

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return

Ionic Capital Management New York $119M AUM 48.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sculptor Capital New York $8.88B AUM 27.49% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return